Literature DB >> 14564563

Pentobarbital and ketamine suppress serum concentrations of sex hormones in the female rat.

C J Lee1, B R Do, J K Kim, Y D Yoon.   

Abstract

PURPOSE: To investigate the potential effects of pentobarbital and ketamine on serum concentrations of sex hormones, the present study was performed using pregnant mare serum gonadotropin (PMSG)-primed cyclic female Sprague-Dawley rats.
METHODS: Pentobarbital sodium (37 mg.kg(-1), i. p.) or ketamine-hydrochloride (229 mg.kg(-1), i. m.) was injected 2 and 3 days after PMSG treatment. At 0, 1, 2, 3, 4, and 5 days after PMSG treatment, sera were collected by cardiac puncture. The serum concentrations of progesterone (P(4)), testosterone (T), and estradiol-17 beta (E(2)) were determined by radioimmunoassay.
RESULTS: The serum concentrations of P(4) tended to be lower in both the pentobarbital- and the ketamine-treated groups compared with the control group. Significant differences were found on days 3 and 4 after pentobarbital and on days, 1, 4, and 5 after ketamine administration. Serum concentrations of T were also suppressed in both the pentobarbital and the ketamine-treated groups, whereas E(2) concentrations decreased only in the ketamine-treated group.
CONCLUSION: Pentobarbital and ketamine decrease serum sex hormone concentrations in PMSG-primed female rats.

Entities:  

Year:  2000        PMID: 14564563     DOI: 10.1007/s005400070003

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  4 in total

1.  Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System.

Authors:  Haoning Guo; Bin Wang; Shuying Yuan; Silin Wu; Jing Liu; Miaoquan He; Jisheng Wang
Journal:  Front Pharmacol       Date:  2022-04-08       Impact factor: 5.988

2.  Ketamine attenuates cytochrome p450 aromatase gene expression and estradiol-17β levels in zebrafish early life stages.

Authors:  William J Trickler; Xiaoqing Guo; Elvis Cuevas; Syed F Ali; Merle G Paule; Jyotshna Kanungo
Journal:  J Appl Toxicol       Date:  2013-05-20       Impact factor: 3.446

3.  Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing rats.

Authors:  Anna A Rybczynska; Philip H Elsinga; Jurgen W Sijbesma; Kiichi Ishiwata; Johan R de Jong; Erik F de Vries; Rudi A Dierckx; Aren van Waarde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-27       Impact factor: 9.236

4.  Gender differences in subjective discontinuation symptoms associated with ketamine use.

Authors:  Wen-Yin Chen; Ming-Chyi Huang; Shih-Ku Lin
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.